SCHEMBL2593958

SCHEMBL2593958

COc1ccc(-c2ccc3c(c2)COC3=O)c(OC[C]2CC2)c1OC

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 12/20 0.47
PRF1 P14222 2/20 0.46
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
CYP3A4 P08684 1/20 0.45
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
CYP19A1 P11511 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2591436 0.89 PDE4D (0.48) PDE4DPRF1KDM4ELMNACYP3A4
SCHEMBL17599593 0.86 PRF1 (0.47) PDE4DPRF1KDM4ELMNACYP3A4
SCHEMBL7716197 0.85 PRF1 (0.46) PDE4DPRF1KDM4ELMNACYP3A4
SCHEMBL2589787 0.84 PRF1 (0.48) PDE4DPRF1KDM4ELMNACYP3A4
SCHEMBL2585895 0.84 PDE4D (0.48) PDE4DPRF1KDM4ELMNACYP3A4
SCHEMBL2596115 0.83 CYP3A4 (0.51) PDE4DPRF1KDM4ELMNACYP3A4
SCHEMBL17599585 0.83 PDE4D (0.48) PDE4DPRF1KDM4ELMNACYP3A4
SCHEMBL2584360 0.83 PRF1 (0.48) PDE4DPRF1KDM4ELMNACYP3A4
SCHEMBL2592360 0.83 PRF1 (0.51) PDE4DPRF1KDM4ELMNACYP3A4
SCHEMBL17599629 0.83 HSD17B1 (0.49) PDE4DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2563770-B1 BIARYL PHOSPHODIESTERASE INHIBITORS LEO PHARMA AS (DK) 2016-03-23 EP disclosed
EP-2563770-A1 BIARYL PHOSPHODIESTERASE INHIBITORS Leo Pharma A/S (DK) 2013-03-06 EP disclosed
WO-2011134468-A1 BIARYL PHOSPHODIESTERASE INHIBITORS LEO PHARMA A/S (DK) 2011-11-03 WO disclosed